Ceva advances swine health at ESPHM 2026

Ceva Animal Health reinforced its position as a global leader in swine health during the European Symposium of Porcine Health Management (ESPHM) 2026, showcasing an outstanding scientific and commercial presence throughout the congress.

Bringing together around 1,500 professionals from across the swine industry — including experts in pharmaceuticals, nutrition, genetics, husbandry and technology — ESPHM 2026 highlighted the latest innovations and scientific developments shaping the future of pig production. More than 450 scientific articles were presented during the event, reflecting the scale and importance of knowledge-sharing within the sector.

Ceva made a strong impact throughout the congress with a highly visited exhibition booth and an extensive scientific contribution that clearly distinguished the company within the industry.

In total, Ceva submitted 72 abstracts, representing 16% of all scientific evidence, field data and applied science presented at the congress — the largest contribution from any company attending the event.

Beyond the exhibition area, Ceva also hosted an exclusive pre-congress symposium focused on Respiratory and Enteric Health. The session welcomed 150 customers and industry professionals from across the European Union, Ukraine, China and Israel, creating a valuable platform for international exchange and collaboration.

Ceva’s presence at ESPHM 2026 also attracted significant industry attention, generating media coverage from leading swine publications including Pig333 and PigProgress, further recognizing the company’s scientific leadership and commitment to innovation.

The company’s participation at ESPHM 2026 reflects Ceva’s ongoing dedication to advancing swine health through science, field evidence and global collaboration. With the largest scientific contribution at the congress and a comprehensive symposium program, Ceva continues to transform research into practical solutions that support pig producers worldwide.